For people who have survived a heart attack, the notion of one shot in the arm to help the heart heal, for weeks after, may ...
Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
These days, streaming services are a dime a dozen. Disney+ remains one of the most popular services, largely because of the amount of exclusive content. You'll not only have access to dozens of Disney ...
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
A Catholic nonprofit and several clergy said immigration authorities had unlawfully blocked its members for months from providing pastoral care at an ICE facility in Broadview, Ill. By Ashley Ahn A ...
Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 weeks.
Joseph Anaya, MD, and Ashkan Abbey, MD, discuss how retina specialists identify appropriate candidates for complement inhibitor therapy in geographic atrophy, set patient expectations, and monitor ...
Whether you're a tech junkie or a casual user who's seen every era of computing, you likely have plenty of old tech ephemera in your home. Maybe it's a desk drawer or closet (or even a tote) filled ...
A special election on a redistricting amendment is scheduled for April 21 in parts of Virginia. The amendment faces ongoing legal challenges, but local registrars are preparing for the election as ...
Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results